$16.47
1.32% today
NYSE, Nov 26, 03:16 pm CET
ISIN
US8816242098
Symbol
TEVA
Sector
Industry

Teva Pharmaceutical Industries Limited Sponsored ADR Stock News

Neutral
GlobeNewsWire
about 16 hours ago
TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and Eric Hughes, Teva's Executive Vice President of Global R&D and Chief Medical Officer, will present at the 7th Annual Evercore ISI HealthCONx Conference on Thursday, December 5, 2024. The presentation will begin at 8:20 ...
Neutral
Seeking Alpha
7 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Jefferies London Healthcare Conference November 19, 2024 3:30 AM ET Company Participants Richard Francis - President & CEO Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo Good morning, everyone. Thanks for joining us.
Neutral
GlobeNewsWire
18 days ago
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024. The presentation will begin at 8:30 A.M. Greenwich Mean Time (3.30 A.M. Eastern Time).
Neutral
Seeking Alpha
20 days ago
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - Head of R&D & Chief Medical Officer Ran Meir - SVP, head of IR Conference Call Participants Umer Raffat - Evercore ISI Balaji Prasad - Barclays David Amsellem - Piper Sandler Jason Gerberry - Bank of...
Positive
Reuters
20 days ago
Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, chief executive Richard Francis said on Wednesday.
Positive
Investors Business Daily
20 days ago
Teva stock jumped early Wednesday after the company reported better-than-expected third-quarter sales and profit. The post Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report appeared first on Investor's Business Daily.
Positive
Reuters
20 days ago
Teva Pharmaceutical Industries reported a larger than expected rise in third-quarter profit, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington's disease.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today